Inhibition of cyclin-dependent kinase 5 activity alleviates diabetes-related cognitive deficits

Wei Liu1, Yi Zhou2, Rui Liang1

  • 1Department of Pathology, The Second Hospital of Hebei Medical University, Hebei Medical University, Shijiazhuang, China.

Insights

Diabetic cognitive deficits are linked to increased cyclin-dependent kinase 5 (Cdk5) activity. Inhibiting Cdk5 reduces neuronal apoptosis and improves cognitive function in diabetic mice, offering a potential therapeutic target.

Area of Science:

  • Neuroscience
  • Endocrinology
  • Molecular Biology

Background:

  • Diabetes mellitus is associated with cognitive deficits, but underlying mechanisms remain unclear.
  • Aberrant cyclin-dependent kinase 5 (Cdk5) activity is implicated in neurodegenerative diseases.
  • The role of Cdk5 in diabetes-related cognitive impairment requires further investigation.

Purpose of the Study:

  • To investigate the role of Cdk5 in the development of cognitive deficits in diabetes.
  • To explore the molecular mechanisms by which Cdk5 contributes to neuronal damage in hyperglycemia.
  • To evaluate the therapeutic potential of inhibiting Cdk5 activity in diabetic cognitive impairment.

Main Methods:

  • Diabetic mouse model and primary cultured hippocampal neurons exposed to high glucose.
  • Assessment of Cdk5 protein expression, kinase activity, and activation by its cofactor p25.
  • Inhibition of Cdk5 using roscovitine (Ros) or short hairpin RNA (shRNA).
  • Evaluation of apoptosis markers (caspase-3, Bax/Bcl-2 ratio, TUNEL, Annexin V/propidium iodide staining).
  • Analysis of the MKK6/p38 MAPK signaling pathway.
  • Behavioral testing to assess cognitive function in diabetic mice.

Main Results:

  • Cdk5 protein expression and kinase activity were significantly elevated in diabetic mice and high glucose-treated neurons.
  • High glucose induced aberrant Cdk5 activation via p25 cleavage by calpain.
  • Cdk5 inhibition reduced neuronal apoptosis by decreasing cleaved caspase-3 and altering Bax/Bcl-2 ratio.
  • Cdk5 inhibition attenuated the activation of the MKK6/p38 MAPK pathway.
  • Treatment with roscovitine significantly alleviated cognitive deficits in diabetic mice.

Conclusions:

  • Aberrant Cdk5 activity in hyperglycemia promotes hippocampal neuron apoptosis through the MKK6/p38 MAPK cascade.
  • Inhibition of Cdk5 overactivation mitigates neuronal apoptosis and cognitive deficits.
  • Targeting Cdk5 offers a promising strategy for treating diabetic neurotoxicity and cognitive impairment.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
385
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.0K
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
6.4K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.3K
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
525